Effects of Camouflage on the Life Quality of Patients With Vitiligo
NCT03540966 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2018-05-30
Summary
Vitiligo is a common depigmented skin disease characterized by destruction of functional melanocyte.The recent therapies to vitiligo are including oral or external glucocorticoids, antioxidants, calcineurin inhibitors or phototherapy. However, long treatment period and unsatisfactory curative effects still exist, which confer long-term psychological burden to patients. As above concerns, it is of great value to explore therapeutic methods that can effectively control disease, improve appearance, relieve patients' pain and improve their quality of life. Current problem is the lack of a vitiligo life quality evaluation scale with Chinese characteristics for us. Therefore, it is necessary for the investigator to compile a vitiligo quality of life scale that is simple, feasible and applicable to China's national conditions. Meanwhile the reliability analysis must be carried out to bring better quality of life assessment tools to patients with vitiligo in China. Previous studies recommended that CapulinTM showing a good cover effect on vitiligo, but the effects of camouflage on the QoL of patients with vitiligo in Chinese population is unknown. Thus, the investigators undergo a randomized open-label controlled study to estimate the effects of CapulinTM on QoL of patients with vitiligo.
Conditions
- Quality of Life
Interventions
- COMBINATION_PRODUCT
-
CapulinTM
a kind of camouflage agent
- OTHER
-
Chinese version of the vitiligo life quality index, VLQI-C
a questionaire designed for patients with vitiligo
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Principal Investigators
-
Chunying Li · Principal Investigator
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2019-01-31
- Completion
- 2020-01-31
Countries
- China
Study Locations
More Related Trials
-
T Central Memory Cells in Early Localized Non-Segmental Vitiligo
NCT05706636 ·Status: COMPLETED ·Phase: NA
-
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
NCT07307534 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
NCT05037981 ·Status: COMPLETED
-
UVA 1 Phototherapy for Vitiligo
NCT01787695 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
NCT03123016 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo
NCT04765826 ·Status: UNKNOWN ·Phase: NA
-
Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo
NCT05238077 ·Status: TERMINATED ·Phase: NA
-
Topical Ruxolitinib for the Treatment of Vitiligo
NCT02809976 ·Status: COMPLETED ·Phase: PHASE2
-
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
NCT04942860 ·Status: COMPLETED ·Phase: PHASE3
-
Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo
NCT05233735 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo
NCT03608917 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients
NCT05467839 ·Status: COMPLETED ·Phase: NA
-
Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
NCT00367224 ·Status: COMPLETED ·Phase: NA
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo
NCT04171427 ·Status: UNKNOWN ·Phase: NA
-
Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
NCT00907062 ·Status: COMPLETED ·Phase: PHASE1
-
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
NCT00771355 ·Status: TERMINATED
-
Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo
NCT05577637 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Red Light in Vitiligo
NCT01787708 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo
NCT01923142 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
NCT06109649 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Treatment and Complication of Bath PUVA in Vitiligo
NCT00380471 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma
NCT03155698 ·Status: UNKNOWN ·Phase: NA
-
Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
NCT01006421 ·Status: UNKNOWN
-
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
NCT04103060 ·Status: COMPLETED ·Phase: PHASE2